These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36562497)

  • 21. Survival outcomes of stenting outflow graft stenosis in continuous-flow left ventricular assist devices: a systematic review.
    Wood CT; O'Malley TJ; Maynes EJ; Vishnevsky A; Morris RJ; Samuels LE; Massey HT; Tchantchaleishvili V
    Heart Fail Rev; 2020 Nov; 25(6):985-992. PubMed ID: 31820204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanical Device Malfunction of the HeartMate II Versus the HeartMate 3 Left Ventricular Assist Device: The Rotterdam Experience.
    van der Heiden CW; Zijderhand CF; Veen KM; Constantinescu AA; Manintveld OC; Brugts JJ; Bekkers JA; Birim O; Bogers AJJC; Caliskan K
    ASAIO J; 2023 Feb; 69(2):e80-e85. PubMed ID: 36516019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrinsic outflow graft flow obstruction in patients with HeartMate3 LVAD.
    Ajello S; Pieri M; Bertoglio L; Altizio S; Nardelli P; Scandroglio AM
    Artif Organs; 2023 Apr; 47(4):786-790. PubMed ID: 36385253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term single-centre experience with the HeartMate 3 left ventricular assist device for advanced heart failure.
    Nowacka A; Hullin R; Tozzi P; Barras N; Regamey J; Yerly P; Rosner L; Marcucci C; Rusca M; Liaudet L; Kirsch M
    Eur J Cardiothorac Surg; 2020 Sep; 58(3):511-518. PubMed ID: 32236472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of outflow graft stenting in HeartMate 3 left ventricular assist devices: A systematic review and individual patient data meta-analysis.
    Patil S; Ahmad D; Shah K; Vishnevsky A; Ruggiero NJ; Rajapreyar IN; Rame JE; Alvarez RJ; Rajagopal K; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2024 Jun; 48(6):577-585. PubMed ID: 38577853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late inflow or outflow obstruction requiring surgical intervention after HeartMate 3 left ventricular assist device insertion.
    Kaku Y; Naka Y; Witer L; Topkara V; Colombo P; Sayer G; Uriel N; Takeda K
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):626-628. PubMed ID: 32888010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
    Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
    J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LVAD decommissioning for myocardial recovery: Long-term ventricular remodeling and adverse events.
    Gerhard EF; Wang L; Singh R; Schueler S; Genovese LD; Woods A; Tang D; Smith NR; Psotka MA; Tovey S; Desai SS; Jakovljevic DG; MacGowan GA; Shah P
    J Heart Lung Transplant; 2021 Dec; 40(12):1560-1570. PubMed ID: 34479776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of computed tomography angiography for HeartMate II left ventricular assist device thrombosis.
    Yu SN; Han J; Takeda K; Ginns JN; Kurlansky PA; Garan AR; Yuzefpolskaya M; Topkara VK; Colombo PC; Naka Y; Takayama H
    Int J Artif Organs; 2018 Jun; 41(6):325-332. PubMed ID: 29562790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bowel obstruction due to retained intraperitoneal left ventricular assist device (LVAD) driveline.
    Miklin D; Lewis I; Lieberman H
    J Cardiothorac Surg; 2018 May; 13(1):46. PubMed ID: 29783995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty.
    Gyoten T; Rojas SV; Fox H; Hata M; Deutsch MA; Schramm R; Gummert JF; Morshuis M
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):855-862. PubMed ID: 33367693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous Intervention for Left Ventricular Assist Device Outflow Obstruction.
    Barac YD; Alwair H; DeNino WF; Ghadimi K; Patel CB; Zomorodi AR; Long C; Schroder JN; Milano CA; Daneshmand MA
    Heart Lung Circ; 2020 Mar; 29(3):e25-e27. PubMed ID: 31530478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left Ventricular Assist Device Outflow Graft Obstruction: A Case Series.
    Nathan S; Ghotra AS; Rajagopal K; Patel C; Kumar S; Patel M; Salas de Armas I; Jumean M; Akay MH; Akkanti B; Kar B; Gregoric ID
    ASAIO J; 2020 Jun; 66(6):657-662. PubMed ID: 31425271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.